- Home
- AXSM vs HUN Comparison
AXSM vs HUN Comparison
Compare AXSM & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- HUN
- Stock Information
- Founded
- AXSM 2012
- HUN 1970
- Country
- AXSM United States
- HUN United States
- Employees
- AXSM N/A
- HUN N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- HUN Major Chemicals
- Sector
- AXSM Health Care
- HUN Industrials
- Exchange
- AXSM Nasdaq
- HUN Nasdaq
- Market Cap
- AXSM 4.0B
- HUN 4.1B
- IPO Year
- AXSM 2015
- HUN 2005
- Fundamental
- Price
- AXSM $91.03
- HUN $21.28
- Analyst Decision
- AXSM Strong Buy
- HUN Buy
- Analyst Count
- AXSM 14
- HUN 9
- Target Price
- AXSM $124.57
- HUN $25.56
- AVG Volume (30 Days)
- AXSM 421.5K
- HUN 1.7M
- Earning Date
- AXSM 11-04-2024
- HUN 10-29-2024
- Dividend Yield
- AXSM N/A
- HUN 4.69%
- EPS Growth
- AXSM N/A
- HUN N/A
- EPS
- AXSM N/A
- HUN N/A
- Revenue
- AXSM $291,489,000.00
- HUN $5,953,000,000.00
- Revenue This Year
- AXSM $42.50
- HUN $1.34
- Revenue Next Year
- AXSM $69.28
- HUN $7.22
- P/E Ratio
- AXSM N/A
- HUN N/A
- Revenue Growth
- AXSM 59.73
- HUN N/A
- 52 Week Low
- AXSM $55.02
- HUN $19.91
- 52 Week High
- AXSM $98.40
- HUN $27.01
- Technical
- Relative Strength Index (RSI)
- AXSM 55.83
- HUN 44.80
- Support Level
- AXSM $91.52
- HUN $21.19
- Resistance Level
- AXSM $96.56
- HUN $22.26
- Average True Range (ATR)
- AXSM 2.95
- HUN 0.51
- MACD
- AXSM 0.13
- HUN 0.03
- Stochastic Oscillator
- AXSM 44.47
- HUN 32.29
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About HUN Huntsman Corporation
Huntsman Corp is a us-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives most of its revenue from the Polyurethanes segment which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.